Gujarat Terce Laboratories Intrinsic Value
Gujarat Terce Laboratories (GUJTERC) median intrinsic value is ₹39.79 from 8 valuation models (range ₹16–₹69), vs current price ₹34.71 — +14.6% upside (Trading Below Median Value), margin of safety 12.8%. Browse GUJTERC balance sheet details for revenue, profit, balance sheet and cash flow data.
GUJTERC Valuation Methods Summary — DCF, Graham Number & P/E
Gujarat Terce Laboratories intrinsic value across 8 models vs current price ₹34.71 — upside/downside and value range per method. For current market price and key ratios, visit Gujarat Terce Laboratories share price chart.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹53.68 | ₹42.94 - ₹64.42 | +54.7% | EPS: ₹2.44, Sector P/E: 22x |
| Book Value Method | asset | ₹20.00 | ₹18.00 - ₹22.00 | -42.4% | Book Value/Share: ₹10.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹69.42 | ₹62.48 - ₹76.36 | +100.0% | Revenue/Share: ₹57.14, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹57.14 | ₹51.43 - ₹62.85 | +64.6% | EBITDA: ₹4.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹39.79 | ₹31.83 - ₹47.75 | +14.6% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹15.62 | ₹14.06 - ₹17.18 | -55.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹37.70 | ₹33.93 - ₹41.47 | +8.6% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| Graham Defensive Method | conservative | ₹20.00 | ₹18.00 - ₹22.00 | -42.4% | EPS: ₹2.44, BVPS: ₹10.00 |
GUJTERC Intrinsic Value vs Market Price — All Valuation Models
Gujarat Terce Laboratories fair value range ₹16–₹69 vs current market price ₹34.71 across 8 valuation models. Also explore GUJTERC price movement history to track price trends across different timeframes.
GUJTERC Intrinsic Value Analysis — Undervalued or Overvalued?
Gujarat Terce Laboratories median intrinsic value ₹39.79, current price ₹34.71 — Trading Below Median Value by 14.6%, margin of safety 12.8%.
What is the intrinsic value of GUJTERC?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Gujarat Terce Laboratories (GUJTERC) is ₹39.79 (median value). With the current market price of ₹34.71, this represents a +14.6% variance from our estimated fair value.
The valuation range spans from ₹15.62 to ₹69.42, indicating ₹15.62 - ₹69.42.
Is GUJTERC undervalued or overvalued?
Based on our multi-method analysis, Gujarat Terce Laboratories (GUJTERC) appears to be trading below median value by approximately 14.6%.
GUJTERC Financial Health — Key Ratios vs Industry Benchmarks
Gujarat Terce Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Operating Margin | 5.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.74x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
GUJTERC Cash Flow Quality — Operating & Free Cash Flow
Gujarat Terce Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |